Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating biomarkers in melanoma
Panagiotis Karagiannis, Matthew W. Fittall, Sophia N. Karagiannis
Frontiers in Oncology (2014) Vol. 4
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Inhibitory Receptors Beyond T Cell Exhaustion
Silvia A. Fuertes Marraco, Natalie J. Neubert, Grégory Verdeil, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 212
M1 and M2 macrophages’ clinicopathological significance in cutaneous melanoma
Monica Falleni, Federica Savi, Delfina Tosi, et al.
Melanoma Research (2017) Vol. 27, Iss. 3, pp. 200-210
Closed Access | Times Cited: 97
BRAF inhibitors: resistance and the promise of combination treatments for melanoma
Merope Griffin, Daniele Scotto, Debra H. Josephs, et al.
Oncotarget (2017) Vol. 8, Iss. 44, pp. 78174-78192
Open Access | Times Cited: 95
The miRNAs Role in Melanoma and in Its Resistance to Therapy
Francesca Varrone, Emilia Caputo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 878-878
Open Access | Times Cited: 71
Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study
Sebastián Podlipnik, Cristina Carrera, Marcelo Sánchez, et al.
Journal of the American Academy of Dermatology (2016) Vol. 75, Iss. 3, pp. 516-524
Closed Access | Times Cited: 64
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma
Panagiotis Karagiannis, Federica Villanova, Debra H. Josephs, et al.
OncoImmunology (2015) Vol. 4, Iss. 11
Open Access | Times Cited: 57
Nanodelivery systems for cutaneous melanoma treatment
Irina Pereira, Carina Monteiro, Miguel Pereira‐Silva, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 184, pp. 214-247
Open Access | Times Cited: 16
Metastatic pathways in patients with cutaneous melanoma
Nikki R. Adler, Andrew Haydon, Catriona McLean, et al.
Pigment Cell & Melanoma Research (2016) Vol. 30, Iss. 1, pp. 13-27
Open Access | Times Cited: 47
Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
Wahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
OncoImmunology (2016) Vol. 5, Iss. 6, pp. e1154250-e1154250
Open Access | Times Cited: 45
The Future of Precision Medicine in Oncology
Lori Millner, Lindsay N. Strotman
Clinics in Laboratory Medicine (2016) Vol. 36, Iss. 3, pp. 557-573
Closed Access | Times Cited: 43
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
Vera Hirsh, Sandro Pignata, Melissa Bersanelli, et al.
Journal of Translational Medicine (2017) Vol. 15, Iss. S1
Open Access | Times Cited: 42
Selective Electrochemical Biosensors for Tyrosinase and Tyramine via Enzyme-Mediated Oxidation Reaction
Islam M. Mostafa, Abubakar Abdussalam, Hao Jiang, et al.
Analytical Chemistry (2025)
Closed Access
Assessment of telomeres expression in melanoma and cutaneous squamous cell carcinoma: correlation with clinical parameters
Tuqa Nasser Alsurhi, Asem Shalaby, Shadia Al-Sinawi, et al.
Clinical & Translational Oncology (2025)
Closed Access
Molecular Markers and Targeted Therapeutics in Metastatic Tumors of the Spine
C. Rory Goodwin, Nancy Abu-Bonsrah, Laurence D. Rhines, et al.
Spine (2016) Vol. 41, Iss. 20, pp. S218-S223
Closed Access | Times Cited: 38
T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines
Angela Vasaturo, Altuna Halilović, Kalijn F. Bol, et al.
Cancer Research (2016) Vol. 76, Iss. 12, pp. 3496-3506
Open Access | Times Cited: 37
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early‐stage melanoma
Idoia Ortega‐Martínez, Jesús Gardeazábal, Asier Erramuzpe, et al.
International Journal of Cancer (2016) Vol. 139, Iss. 7, pp. 1598-1607
Open Access | Times Cited: 37
A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma
Jin Song, Shannath L. Merbs, Lori J. Sokoll, et al.
Clinical Proteomics (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 34
Development of an electrochemical biosensor for Galectin-3 detection in point-of-care
Sofia M.V. Cerqueira, Rúben Fernandes, Felismina T.C. Moreira, et al.
Microchemical Journal (2021) Vol. 164, pp. 105992-105992
Open Access | Times Cited: 25
Plasmacytoid Dendritic Cell Impairment in Metastatic Melanoma by Lactic Acidosis
Matilde Monti, Raffaella Vescovi, Francesca Consoli, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2085-2085
Open Access | Times Cited: 27
Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients
A. Fröhlich, Dennis Niebel, Simon Fietz, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 5, pp. 759-769
Open Access | Times Cited: 25
Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study
Filippo Mancuso, Sergio Lage, Javier Rasero, et al.
Molecular Oncology (2020) Vol. 14, Iss. 8, pp. 1705-1718
Open Access | Times Cited: 24
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers
Nicole J. Toney, Lynn M. Opdenaker, Kader Cicek, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Microsomal PGE2 synthase‐1 regulates melanoma cell survival and associates with melanoma disease progression
Sun‐Hee Kim, Yuuri Hashimoto, Sung‐Nam Cho, et al.
Pigment Cell & Melanoma Research (2016) Vol. 29, Iss. 3, pp. 297-308
Open Access | Times Cited: 26
The Interplay between Tumour Microenvironment Components in Malignant Melanoma
Cornelia Amălinei, Adriana Grigoraş, Ludmila Lozneanu, et al.
Medicina (2022) Vol. 58, Iss. 3, pp. 365-365
Open Access | Times Cited: 13
Biomarkers in Malignant Melanoma: Recent Trends and Critical Perspective
Birgit Belter, Cathleen Haase‐Kohn, Jens Pietzsch
Codon Publications eBooks (2017), pp. 39-56
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top